What does Cysteamine Bitartrate (Procysbi, Cystagon) do in plain English—and how does it work inside your body?
Cysteamine Bitartrate is an FDA-regulated Cystine Depleting Agent (RxNorm RxCUI 1421467). Mechanistically, 12.1 Mechanism of Action Cysteamine is an aminothiol that participates within lysosomes in a thiol-disulfide interchange reaction converting cystine into cysteine and cysteine-cysteamine mixed disulfide, both of which can exit the lysosome in patients with cystinosis. [1][2].
When your doctor writes a prescription for Cysteamine Bitartrate (RxNorm RxCUI 1421467, also dispensed under brand names including Procysbi, Cystagon), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Cysteamine is an aminothiol that participates within lysosomes in a thiol-disulfide interchange reaction converting cystine into cysteine and cysteine-cysteamine mixed disulfide, both of which can exit the lysosome in patients with cystinosis. [2].
Across real-world patient logs on dotMD (80% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Cysteamine Bitartrate tablet bottle and confirm with your pharmacist that it matches your prescribed strength (75 mg/1 Granule, Delayed Release, 50 mg/1 Capsule, 300 mg/1 Granule, Delayed Release, 150 mg/1 Capsule, 25 mg/1 Capsule, Delayed Release Pellets).